Lin Li, Zhang Li-Juan
Department of Obstetrics and Gynecology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):900-3.
To investigate the role of CD(4)(+)CD(25)(+) regulatory T cells and CD(4)(+)CD(25)(high) regulatory T cells in peripheral blood and decidua in the pathogenesis of intrahepatic cholestasis of pregnancy (ICP).
Peripheral blood and decidua CD(4)(+)CD(25)(+) regulatory T cells and CD(4)(+)CD(25)(high) regulatory T cells in 30 ICP patients (15 mild ICP and 15 severe ICP) and 28 normal pregnant women were analyzed by flow cytometry.
The percentage of CD(4)(+)CD(25)(+) regulatory T cells and CD(4)(+)CD(25)(high) regulatory T cells in the CD(4)(+) T cells population in both peripheral blood and decidua in ICP patients were significantly lower than those in control women [(7.96 +/- 1.32)% vs (17.05 +/- 2.86)%, (17.18 +/- 2.27)% vs (32.01 +/- 3.88)%; (0.78 +/- 0.22)% vs (1.71 +/- 0.69)%, (2.25 +/- 0.89)% vs (8.30 +/- 1.13)%; P < 0.01]. Meanwhile, a significantly higher percentage of CD(4)(+)CD(25)(+) regulatory T cells and CD(4)(+)CD(25)(high) regulatory T cells in the CD(4)(+) T cells population was observed in all decidua samples compared to peripheral blood both in ICP patients (P < 0.01) and in control women (P < 0.01). In addition, the percentages of CD(4)(+)CD(25)(+) regulatory T cells and CD(4)(+)CD(25)(high) regulatory T cells in the CD(4)(+) T cell population in both decidua and peripheral blood in severe ICP [(15.94 +/- 1.95)%, (7.17 +/- 1.17)%, (1.87 +/- 0.90)%, (0.68 +/- 0.19)%] were lower than those in mild ICP [(18.43 +/- 1.90)%, (8.74 +/- 0.96)%, (2.62 +/- 0.72)%, (0.89 +/- 0.20)%] and normal pregnancy (all P < 0.05).
CD(4)(+)CD(25)(high) regulatory T cell may play an important role in the pathogenesis of ICP and control of disease progression.
探讨CD4⁺CD25⁺调节性T细胞和CD4⁺CD25⁺高表达调节性T细胞在外周血及蜕膜中在妊娠期肝内胆汁淤积症(ICP)发病机制中的作用。
采用流式细胞术分析30例ICP患者(15例轻度ICP和15例重度ICP)及28例正常孕妇外周血和蜕膜中CD4⁺CD25⁺调节性T细胞和CD4⁺CD25⁺高表达调节性T细胞。
ICP患者外周血和蜕膜中CD4⁺T细胞群体中CD4⁺CD25⁺调节性T细胞和CD4⁺CD25⁺高表达调节性T细胞的百分比均显著低于对照组女性[(7.96±1.32)%对(17.05±2.86)%,(17.18±2.27)%对(32.01±3.88)%;(0.78±0.22)%对(1.71±0.69)%,(2.25±0.89)%对(8.30±1.13)%;P<0.01]。同时,在ICP患者(P<0.01)和对照组女性(P<0.01)中,所有蜕膜样本中CD4⁺T细胞群体中CD4⁺CD25⁺调节性T细胞和CD4⁺CD25⁺高表达调节性T细胞的百分比均显著高于外周血。此外,重度ICP患者蜕膜和外周血中CD4⁺T细胞群体中CD4⁺CD25⁺调节性T细胞和CD4⁺CD25⁺高表达调节性T细胞的百分比[(15.94±1.95)%,(7.17±1.17)%,(1.87±0.90)%,(0.68±0.19)%]低于轻度ICP患者[(18.43±1.90)%,(8.74±0.96)%,(2.62±0.72)%,(0.89±0.20)%]和正常妊娠组(均P<0.05)。
CD4⁺CD25⁺高表达调节性T细胞可能在ICP发病机制及疾病进展控制中起重要作用。